Recombinant Ephrin B1 (EFNB1)

CFND; CFNS; EFL3; EPLG2; Elk-L; LERK2; EPH-related receptor tyrosine kinase ligand 2; Craniofrontonasal Syndrome(Craniofrontonasal Dysplasia)

  • Recombinant Ephrin B1 (EFNB1) Packages (Simulation)
  • Recombinant Ephrin B1 (EFNB1) Packages (Simulation)
  • RPE114Ra01.jpg Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Ephrin B1 (EFNB1)

USAGE of the Recombinant Ephrin B1 (EFNB1)

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Recombinant Ephrin B1 (EFNB1)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Ephrin B1 (EFNB1)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Rattus norvegicus (Rat) Applications (RESEARCH USE ONLY!)
URPE114Ra01 Recombinant Ephrin B1 (EFNB1) Positive Control; Immunogen; SDS-PAGE; WB.
GUESTBOOK